These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27206439)

  • 1. [Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid].
    Choi JH; Heo NY; Park SH; Park CS; Jo KM; Kim WG; Nam KH
    Korean J Gastroenterol; 2016 May; 67(5):267-271. PubMed ID: 27206439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome due to ethambutol.
    Gest N; Ingen-Housz-Oro S; Gener G; Bellanger M; Henn A; Gallien S; Flateau C
    Med Mal Infect; 2018 Jun; 48(4):302-305. PubMed ID: 29602678
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
    Martínez de Lagrán I; Marcos P; Batlle M; Alonso E; Plana A; Tomasa T
    Med Intensiva; 2017 Apr; 41(3):191-193. PubMed ID: 27017438
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.
    Ho CC; Chen YC; Hu FC; Yu CJ; Yang PC; Luh KT
    Clin Infect Dis; 2009 Jun; 48(11):1526-33. PubMed ID: 19400686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome.
    Czapka M; Shukla S; Slosar-Cheah M
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A miliary tuberculosis case without lung involvement difficult to distinguish from autoimmune hepatitis exacerbation].
    Yamashita H; Ueda Y; Takahashi Y; Mimori A
    Kansenshogaku Zasshi; 2014 Jul; 88(4):459-62. PubMed ID: 25199380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
    Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
    J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of tuberculosis].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1990 Nov; 115(47):1799-802. PubMed ID: 2226195
    [No Abstract]   [Full Text] [Related]  

  • 9. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: case report
.
    Kim H; Bang ES; Lim SK; Lee JM
    Int J Clin Pharmacol Ther; 2016 Oct; 54(10):808-15. PubMed ID: 27443659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
    Hoose C
    Prax Pneumol; 1975 Sep; 29(9):517-9. PubMed ID: 1208336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
    Opl G; Benkö M
    Prax Pneumol; 1977 Feb; 31(2):116-20. PubMed ID: 846937
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.
    Coster A; Aerts O; Herman A; Marot L; Horst N; Kenyon C; Vlieghe E; Hainaut P; Baeck M
    Contact Dermatitis; 2019 Nov; 81(5):325-331. PubMed ID: 31021423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications.
    Cheng J; Rawal S; Roberts A; Guttman OR
    Pediatr Infect Dis J; 2013 Dec; 32(12):1388-90. PubMed ID: 24569311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypothermia due to anti-tuberculosis drugs: first case].
    Oualil H; Nejjari S; Bourkadi JE; Iraqi G
    Rev Pneumol Clin; 2014 Oct; 70(5):298-301. PubMed ID: 24646781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tuberculosis.
    McNicol M
    J R Coll Physicians Lond; 1979 Jan; 13(1):23-4. PubMed ID: 762670
    [No Abstract]   [Full Text] [Related]  

  • 18. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
    Özkaya E
    Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles underlying the use of antituberculosis medication in children (author's transl)].
    Ollivier A; Besson-Leaud M
    Sem Hop; 1979 Oct 8-15; 55(33-34):1529-35. PubMed ID: 229564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.